We identified the most dramatic pathway changes in hepatic macrophage from mice fed with high cholesterol, with the upregulation of TNF-α, TGF-β, IFN-α, IL-6, and PDGF signaling pathways, all previously correlated to NASH progression. Here, TGFB1 is linked to metabolic dysfunction-associated steatohepatitis.